Experienced in Pulmonary Embolism

Ismail Hanta

Adana, TR 
Experienced in Pulmonary Embolism
Adana, TR 
OverviewLocationsClinical Research

Overview

Ismail Hanta practices in Adana, Turkey. Mr. Hanta is rated as an Experienced expert by MediFind in the treatment of Pulmonary Embolism. His top areas of expertise are Lymphomatoid Granulomatosis, Sarcoidosis, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis.

His clinical research consists of co-authoring 37 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Pulmonary Embolism.

Gender
Male

Locations

Adana, 01330, Turkey
Other Locations
Yuregir, 01250, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Comparison of Bronchodilator Efficacy of Tiotropium/Salmeterol/Fluticasone 9/50/500 mcg Combination Treatment Administered Via Discair® With Original Products Seretide Diskus 500 mcg Inhalation Powder Plus Spiriva 18 mcg Inhalation Powder Treatment in Patients With Moderate-severe Chronic Obstructive Pulmonary Disease (COPD)
Comparison of Bronchodilator Efficacy of Tiotropium/Salmeterol/Fluticasone 9/50/500 mcg Combination Treatment Administered Via Discair® With Original Products Seretide Diskus 500 mcg Inhalation Powder Plus Spiriva 18 mcg Inhalation Powder Treatment in Patients With Moderate-severe Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 4
Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
Enrollment Status: Terminated
Publish Date: September 25, 2019
View 1 Less Clinical Trial

37 Total Publications

Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors.
Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors.
Journal: Medicina (Kaunas, Lithuania)
Published: June 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hanta's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile